1. Home
  2. RLI vs ALKS Comparison

RLI vs ALKS Comparison

Compare RLI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLI Corp. (DE)

RLI

RLI Corp. (DE)

HOLD

Current Price

$63.03

Market Cap

5.4B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$34.93

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLI
ALKS
Founded
1965
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.7B
IPO Year
1985
1991

Fundamental Metrics

Financial Performance
Metric
RLI
ALKS
Price
$63.03
$34.93
Analyst Decision
Hold
Strong Buy
Analyst Count
7
13
Target Price
$66.00
$42.85
AVG Volume (30 Days)
917.0K
2.1M
Earning Date
01-21-2026
02-25-2026
Dividend Yield
4.19%
N/A
EPS Growth
16.73
2.44
EPS
4.37
2.02
Revenue
$1,882,448,000.00
$1,521,338,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.17
$23.22
P/E Ratio
$14.44
$17.31
Revenue Growth
6.33
1.08
52 Week Low
$55.80
$25.17
52 Week High
$81.79
$36.45

Technical Indicators

Market Signals
Indicator
RLI
ALKS
Relative Strength Index (RSI) 60.74 65.45
Support Level $60.00 $33.35
Resistance Level $62.78 $35.34
Average True Range (ATR) 1.50 1.08
MACD 0.64 -0.02
Stochastic Oscillator 96.86 87.37

Price Performance

Historical Comparison
RLI
ALKS

About RLI RLI Corp. (DE)

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: